首頁 > 市場調查報告書 > 生物科技 > 生物材料 > 巴西、印度、中國整形外科用生物材料市場：2011年

聯絡我們?

市場調查報告書

巴西、印度、中國整形外科用生物材料市場：2011年

Brazilian, Indian, and Chinese Markets for Orthopedic Biomaterials 2011

出版商	Millennium Research Group
出版日期	2010年12月	商品編碼	146030
內容資訊	英文
價格	US $ 5995 Web Access and PDF Download (Single user license) US $ 9000 Web Access and PDF Download (Corporate use license)

簡介
目錄
相關商品

巴西、印度、中國整形外科用生物材料市場：2011年 是由出版商Millennium Research Group在2010年12月所出版的。這份英文市場調查報告書價格從美金5995起跳。

簡介

巴西、印度、中國整形外科用生物材料市場隨高齡化影響醫療處理件數增加、對治療環境及意識之改善、可用所得增加、醫療旅遊增加等，預計可順利持續成長。但雖已改善仍對無障礙醫療尚未健全，醫療保障及使用整形外科生物材料治療之償還依然是少數，高額負擔對大多數人來說仍遙不可及。而阿育吠陀及針灸等傳統治療之市場可行性將會越來越小。

本報告為，分析巴西、印度、中國整形外科用生物材料市場，並匯整骨移植物、玻尿酸粘度補充、切割骨間儀器、血小板濃縮系統、膝蓋軟骨修復等市場預測、市場驅力、市場阻力、競合分析等，以下列摘要形式闡述。

實施概要

方法論

第1章整形外科生物材料背景

骨移植物概要
骨性關節炎及玻尿酸粘度補充概要

第2章巴西、印度、中國整形外科用生物材料市場

市場概要
國家概要
市場分析
- 處理
- 市場預測
競合分析

第3章骨移植物替代品

市場概要
市場分析
- 國家別處理
- 材料及應用別處理
- 市場預測
- 市場驅力及阻力
競合分析

第4章玻尿酸粘度補充

市場概要
市場分析
- 治療
- 市場預測
- 市場驅力及阻力
競合分析
競合企業

附錄

圖表

The Brazilian, Indian, and Chinese (BIC) market for orthopedic biomaterials, consisting of bone graft substitutes (BGS) and hyaluronic acid (HA) viscosupplementation, is expanding as procedure volumes and disposable incomes continue to grow in these countries. Procedure growth is being driven primarily by the aging population and the associated increase in age-related ailments, growing awareness of and improved accessibility to treatment, as well as th expanding medical tourism industry. Although improving, accessibility to medical treatment and reimbursement issues continue to inhibit procedure volumes and market potential to some extent; patients in rural areas do not have access to the higher-quality medical care that is focused in urban areas. Procedures involving orthopedic biomaterials are poorly reimbursed, and a large portion of the population still cannot afford these treatments out-of-pocket or through private insurance. The presence of alternative, and more affordable traditional treatments - such as ayurveda, yoga and naturopathy, Unani, Siddha, and homeopathy in India, and traditional Chinese medicine, such as tai chi or acupuncture - will also continue to limit the market' s potential, especially in the HA viscosupplementation market. Nevertheless, as the respective governments in these growing economies continue to invest in health care, accessibility and reimbursement issues will become less inhibitive. Moreover, as discretionary income for the average citizen continues to rise, there will be an increasing shift toward BGS surgeries and HA viscosupplementation treatments.

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

METHODOLOGY

1.0 ORTHOPEDIC BIOMATERIAL BACKGROUND

1.1 Bone Graft Overview
- 1.1.1 Autografts
- 1.1.2 Nonproprietary Allografts
- 1.1.3 Demineralized Bone Matrices
- 1.1.4 Xenografts
- 1.1.5 Synthetics
- 1.1.6 Growth Factors
- 1.1.7 Orthopedic Stem Cell Products
1.2 Osteoarthritis and Hyaluronic Acid Viscosupplementation Overview
- 1.2.1 Treatment Alternatives
  - 1.2.1.1 Nonpharmacologic Treatments
  - 1.2.1.2 Nonsteroidal Anti - Inflammatory Drugs
  - 1.2.1.3 Cyclooxygenase - 2 Inhibitors
  - 1.2.1.4 Hyaluronic Acid Viscosupplementation

2.0 BRAZILIAN, INDIAN, AND CHINESE ORTHOPEDIC BIOMATERIAL MARKET

2.1 Market Overview
2.2 Country Overviews
- 2.2.1 Brazil Overview
- 2.2.2 India Overview
- 2.2.3 China Overview
2.3 Market Analysis
- 2.3.1 Procedures
- 2.3.2 Market Forecast
  - 2.3.2.1 Bone Graft Substitute Market
  - 2.3.2.2 Hyaluronic Acid Viscosupplementation Market
2.4 Competitive Analysis
- 2.4.1 Market Shares

3.0 BONE GRAFT SUBSTITUTE MARKET

3.1 Market Overview
3.2 Market Analysis
- 3.2.1 Procedures by Country
- 3.2.2 Procedures by Material and Application
  - 3.2.2.1 Brazilian Bone Graft Procedures by Material and Application
  - 3.2.2.2 Indian Bone Graft Procedures by Material and Application
  - 3.2.2.3 Chinese Bone Graft Procedures by Material and Application
- 3.2.3 Market Forecast
  - 3.2.3.1 Brazilian Bone Graft Substitute Market
  - 3.2.3.2 Indian Bone Graft Substitute Market
  - 3.2.3.3 Chinese Bone Graft Substitute Market
- 3.2.4 Market Drivers and Limiters
  - 3.2.4.1 Market Drivers
  - 3.2.4.2 Market Limiters
3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.2 Market Shares
- 3.3.3 Competitor Discussions (in Alphabetical Order)
  - Biomet
  - DePuy
  - Medtronic Spinal & Biologics
  - Stryker
  - Synthes
  - Other

4.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

4.1 Market Overview
4.2 Market Analysis
- 4.2.1 Treatments
  - 4.2.1.1 Brazilian Hyaluronic Acid Viscosupplementation Treatments
  - 4.2.1.2 Indian Hyaluronic Acid Viscosupplementation Treatments
  - 4.2.1.3 Chinese Hyaluronic Acid Viscosupplementation Treatments
- 4.2.2 Market Forecast
  - 4.2.2.1 Brazilian Hyaluronic Acid Viscosupplementation Market
  - 4.2.2.2 Indian Hyaluronic Acid Viscosupplementation Market
  - 4.2.2.3 Chinese Hyaluronic Acid Viscosupplementation Market
- 4.2.3 Market Drivers and Limiters
  - 4.2.3.1 Market Drivers
  - 4.2.3.2 Market Limiters
4.3 Competitive Analysis
- 4.3.1 Competitive Landscape
- 4.3.2 Market Shares
- 4.3.3 Competitor Discussions (in Alphabetical Order)
  - Genzyme Biosurgery
  - Fidia Farmaceutici (through distributors TRB PHARMA and Lupin Pharmaceuticals)
  - Seikagaku
  - Shandong Bausch & Lomb Freda Pharmaceutical
  - Shanghai BAIJIAYI Pharmaceutical
  - Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL FIGURES

APPENDIX C: POPULATION STATISTICS